Quality improvement in inflammatory bowel disease

Gastroenterology and Hepatology

Volumn 9, Issue 5, 2013, Pages 286-292

  Melmed, Gil Y ^a   Siegel, Corey A ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Inflammatory bowel disease; Quality indicators; Quality measures; Quality of care

Indexed keywords

ABDOMINAL PAIN; ANEMIA; ARTICLE; CLINICAL FEATURE; CROHN DISEASE; DIARRHEA; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; INFECTION PREVENTION; MALNUTRITION; MEDICAL SOCIETY; OSTEOLYSIS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; QUALITY CONTROL; QUALITY OF LIFE; RISK ASSESSMENT; TOTAL QUALITY MANAGEMENT; ULCERATIVE COLITIS; WEIGHT REDUCTION;

EID: 84878445305     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. http://www.iom.edu/~/media/Files/Report%20Files/2001/ Crossingthe- Quality-Chasm/Quality%20Chasm%202001%20%20report%20brief.pdf. Accessed April 5, 2013.
2. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
3. Asch SM, Kerr EA, Keesey J, et al. Who is at greatest risk for receiving poorquality health care? N Engl J Med. 2006;354:1147-1156.
4. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-2645. (Pubitemid 36741592)
5. Jha AK, Li Z, Orav EJ, et al. Care in U.S. hospitals - the Hospital Quality Alliance program. N Engl J Med. 2005;353:265-274. (Pubitemid 41058326)
6. Reddy SI, Friedman S, Telford JJ, et al. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol. 2005;100:1357-1361. (Pubitemid 40904362)
7. Balas EA, Boren SA. Managing clinical knowledge for health care improvement. In: Bemmel J, McCray AT, eds. Yearbook of Medical Informatics 2000: Patient-Centered Systems. Stuttgart, Germany: Schattauer Verlagsgesellschaft mbH; 2000:65-70.
8. Drossman DA, Patrick DL, Mitchell CM, et al. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379-1386. (Pubitemid 19247394)
9. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol. 2003;98:1064-1072. (Pubitemid 36733768)
10. Nguyen GC, Tuskey A, Dassopoulos T, et al. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007;13:1529-1535.
11. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429. (Pubitemid 350181588)
12. Loftus EV Jr. The burden of inflammatory bowel disease in the United States: a moving target? Clin Gastroenterol Hepatol. 2007;5:1383-1384. (Pubitemid 350181612)
13. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517. (Pubitemid 38649869)
14. Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics. 2002;20:639-652. (Pubitemid 34983368)
15. Feagan BG, Vreeland MG, Larson LR, et al. Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol. 2000;95:1955-1960.
16. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135:1907-1913.
17. Donabedian A. The role of outcomes in quality assessment and assurance. QRB Qual Rev Bull. 1992;18:356-360.
18. Brook RH, McGlynn EA, Cleary PD. Quality of health care. Part 2: measuring quality of care. N Engl J Med. 1996;335:966-970. (Pubitemid 26314453)
19. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's disease in adults. Am J Gastroenterol. 2009;104:465-483; quiz 464, 484.
20. Travis SP, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut. 2006;55(suppl 1):i16-i35. (Pubitemid 43268291)
21. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385. (Pubitemid 39062279)
22. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53(suppl 5):V1-V16. (Pubitemid 39120096)
23. Melmed GY, Spiegel BM, Bressler B, et al. The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all. Clin Gastroenterol Hepatol. 2010;8:655-659.
24. Altschuler A, Collins B, Lewis JD, et al. Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:992-999.
25. Esrailian E, Spiegel BM, Targownik LE, et al. Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes. Aliment Pharmacol Ther. 2007;26:1005-1018. (Pubitemid 47416289)
26. Spiegel BM, Ho W, Esrailian E, et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol. 2009;7:168-174, 174.e1.
27. Kappelman MD, Bousvaros A, Hyams J, et al. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis. 2007;13:890-895. (Pubitemid 47203867)
28. Crandall WV, Margolis PA, Kappelman MD, et al. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012;129:e1030-e1041.
29. Kaplan GG, McCarthy EP, Ayanian JZ, et al. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008;134:680-687.
30. Ananthakrishnan AN, McGinley EL, Binion DG. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Am J Gastroenterol. 2008;103:2789-2798.
31. Melmed G, Ippoliti A, Papadakis K, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101:1834-1840. (Pubitemid 44166594)
32. Yeung JH, Goodman KJ, Fedorak RN. Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients. Inflamm Bowel Dis. 2012;18:34-40.
33. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011;17:2536-2540.
34. Crawford NW, Catto-Smith AG, Oliver MR, et al. An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease. BMC Gastroenterol. 2011;11:87.
35. Wilckens V, Kannengiesser K, Hoxhold K, et al. The immunization status of patients with IBD is alarmingly poor before the introduction of specific guidelines. Scand J Gastroenterol. 2011;46:855-861.
36. Gosk-Bierska I, McBane RD, Waszczuk E, et al. Prevalence of lower extremity venous disease in inflammatory bowel disease. Int Angiol. 2007;26:67-71. (Pubitemid 46851180)
37. Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population- based nationwide study. Gut. 2011;60:937-943.
38. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272-2280.
39. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657-663.
40. Novacek G, Weltermann A, Sobala A, et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology. 2010;139: 779-787, 787.e1.
41. Tinsley A, Naymagon S, Trindade AJ, et al. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol. 2013;47:e1-e6.
42. Long MD, Herfarth HH, Pipkin CA, et al. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2010;8:268-274.
43. Long MD, Martin CF, Pipkin CA, et al. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:390-399.e1.
44. Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011;141:1621-1628.e1-5.
45. IBD Standard Group. Quality Care Service Standards for the Healthcare of People Who Have Inflammatory Bowel Disease (IBD). http://www.ibdstandards.org. uk/uploaded-files/IBDstandards.pdf. Accessed April 5, 2013.
46. Lieberman D, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007;65:757-766. (Pubitemid 46629071)
47. Crandall W, Kappelman MD, Colletti RB, et al. ImproveCareNow: the development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis. 2011;17:450-457.
48. Crandall WV, Boyle BM, Colletti RB, et al. Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:2184-2191.
49. American Gastroenterological Association. Digestive Health Outcomes Registry. http://www.gastro.org/practice/digestive-health-outcomes-registry. Accessed April 5, 2013.
50. Melmed GY, Siegel CA, Spiegel BM, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013;19:662-668.
51. Levine DS. Clinical features and complications of Crohn's disease. In: Targan SR, Shanahan F, eds. Inflammatory Bowel Disease: From Bench to Bedside. Baltimore, Md: Williams and Wilkins; 1993:296-316.